News
Four drugs for rare diseases approved for manufacturing under the production linked incentive (PLI) scheme for pharmaceuticals under the Department of Pharmaceuticals (DoP) are expected to be ...
Ministry of health includes AIIMS Patna as CoE for rare diseases: Our Bureau, New Delhi Thursday, August 21, 2025, 08:00 Hrs [IST] The Union ministry of health and family welfare ...
With global drugs worth over $250 billion going off-patent by 2030, a great opportunity awaits Indian pharma, but one that comes with intense competition and shrinking margins. Capitalizing on the ...
Pharmexcil in talks with stakeholders to launch online logistics platform to streamline logistics operations: Shardul Nautiyal, Mumbai Thursday, August 21, 2025, 08:00 Hrs [IST] T ...
Advances in gallbladder surgery are improving outcomes in high-risk patients: Dr Anushtup De: Shardul Nautiyal, Mumbai Thursday, August 21, 2025, 08:00 Hrs [IST] Advances in gallb ...
Our Bureau, Mumbai Wednesday, August 20, 2025, 17:15 Hrs [IST] ...
US FDA extends review timeline of Regenxbio’s BLA for clemidsogene lanparvovec to treat Mucopolysaccharidosis II: Rockville, Maryland Wednesday, August 20, 2025, 18:00 Hrs [IST] ...
China NMPA grants breakthrough therapy designation to Antengene’s ATG-022 to treat gastric/gastroesophageal junction adenocarcinoma: Shanghai Wednesday, August 20, 2025, 16:00 H ...
RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries: Yantai, China Wednesday, August 20, 2025, 11:00 Hr ...
Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases: Ingelheim, Germany Wednesday, ...
MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar: San Diego, California Wednesday, August 20, 2025, 13:00 Hrs [IST] MedImpact Holdings Inc., the largest independen ...
Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results